MARATTO

article · The International Journal of Biochemistry & Cell Biology

Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascade

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Liver physiology and pathology
  • Liver Disease Diagnosis and Treatment
  • Chemotherapy-induced organ toxicity mitigation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.biocel.2026.106964

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.